EPO and pneumonia: Immunosuppressant administration for 16 days did not increase the occurrence of AEs in groups A and B. In the previous trial, pneumonia and irritability occurred more in the UCB- and the EPO-administered groups, possibly because of the long 1-month duration of immunosuppression treatment [27].